ArticleCancers2022

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma.

Zijian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.